金鸿药业 (831186.OC)

+ 收藏

现金流量表(金鸿药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 355,348,898.35149,801,204.38582,730,841.21224,092,507.35
 收到的税费返还(元) 1,347,890.17306,059.458,267.4717,405.62
 收到其他与经营活动有关的现金(元) 9,336,659.537,877,158.8810,156,768.0619,579.42
 经营活动现金流入小计(元) 366,033,448.05157,984,422.71592,895,876.74224,129,492.39
 购买商品、接受劳务支付的现金(元) 161,371,904.2080,115,245.21121,861,651.5451,669,504.76
 支付给职工以及为职工支付的现金(元) 81,497,326.5244,405,995.5869,594,965.4136,435,200.62
 支付的各项税费(元) 30,948,613.2215,825,632.4241,951,956.0121,879,145.43
 支付其他与经营活动有关的现金(元) 154,983,962.28102,021,113.23219,325,541.43109,560,750.55
 经营活动现金流出小计(元) 428,801,806.22242,367,986.44452,734,114.39219,544,601.36
 经营活动产生的现金流量净额(元) -62,768,358.17-84,383,563.73140,161,762.354,584,891.03
二、投资活动产生的现金流量
 收回投资收到的现金(元) 227,000,000.00-499,000,000.00-
 取得投资收益收到的现金(元) 222,028.74183,427.381,095,324.93591,028.16
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 6,500.00-48,790.0026,990.00
 投资活动现金流入小计(元) 227,228,528.74183,427.38500,144,114.93618,018.16
 购建固定资产、无形资产和其他长期资产支付的现金(元) 47,115,494.9332,745,966.4058,527,134.9725,139,268.44
 投资支付的现金(元) 227,000,000.00-499,000,000.00-
 投资活动现金流出小计(元) 274,115,494.9332,745,966.40557,527,134.9725,139,268.44
 投资活动产生的现金流量净额(元) -46,886,966.19-32,562,539.02-57,383,020.04-24,521,250.28
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 114,000.0024,000.0010,000.00-
  其中:子公司吸收少数股东投资收到的现金(元) 114,000.0024,000.0010,000.00-
 取得借款收到的现金(元) 89,468,546.0015,000,000.0028,384,928.845,483,800.00
 收到其他与筹资活动有关的现金(元) 8,612,220.00-5,359,452.44-
 筹资活动现金流入小计(元) 98,194,766.0015,024,000.0033,754,381.285,483,800.00
 偿还债务支付的现金(元) 87,894,898.8839,082,791.441,003,696.00260,966.00
 分配股利、利润或偿付利息支付的现金(元) 8,936,970.537,077,919.848,850,626.596,292,783.50
  其中:子公司支付给少数股东的股利、利润(元) 28,993.897,448.00--
 支付其他与筹资活动有关的现金(元) 9,578,641.00-8,648,220.00-
 筹资活动现金流出小计(元) 106,410,510.4146,160,711.2818,502,542.596,553,749.50
 筹资活动产生的现金流量净额(元) -8,215,744.41-31,136,711.2815,251,838.69-1,069,949.50
四、汇率变动对现金及现金等价物的影响(元) 38,165.8730,952.42-78,466.57-65,591.65
五、现金及现金等价物净增加额(元) -117,832,902.90-148,051,861.6197,952,114.43-21,071,900.40
 加:期初现金及现金等价物余额(元) 199,356,304.50199,356,304.50101,404,190.07101,404,190.07
 期末现金及现金等价物余额(元) 81,523,401.6051,304,442.89199,356,304.5080,332,289.67
补充资料:
 净利润(元) 7,480,185.2710,564,750.2328,777,001.568,306,379.92
 资产减值准备(元) 699,474.34315,138.48229,905.4377,012.16
 固定资产和投资性房地产折旧(元) 12,900,323.895,752,423.948,079,646.283,806,911.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 12,900,323.895,752,423.948,079,646.283,806,911.49
 无形资产摊销(元) 6,638,319.123,307,960.026,171,220.282,917,044.99
 长期待摊费用摊销(元) 450,191.76175,711.89554,408.48298,532.28
 处置固定资产、无形资产和其他长期资产的损失(元) -526.46--15,640.25-13,247.53
 固定资产报废损失(元) 23,281.88-22,575.49200.17
 财务费用(元) 2,701,123.79958,956.202,137,967.501,051,782.53
 投资损失(元) 20,733.50-183,427.38-1,094,464.56-591,028.16
 递延所得税(元) -1,213,155.18-146,769.67-2,336,402.65-616,235.04
  其中:递延所得税资产减少(元) -855,628.48--5,048,893.56-616,235.04
 递延所得税负债增加(元) -357,526.70-146,769.672,712,490.91-
 存货的减少(元) -16,297,562.57-7,677,123.78-16,319,716.49-12,054,148.58
 经营性应收项目的减少(元) 5,498,938.59-67,661,085.95-1,638,303.21-9,919,942.78
 经营性应付项目的增加(元) -81,428,501.85-29,609,851.80115,267,146.8511,269,089.96
 现金的期末余额(元) 81,523,401.6051,304,442.89199,356,304.5080,332,289.67
 减:现金的期初余额(元) 199,356,304.50199,356,304.50101,404,190.07101,404,190.07
 现金及现金等价物的净增加额(元) -117,832,902.90-148,051,861.6197,952,114.43-21,071,900.40
公告日期 2024-03-292023-08-182023-03-312022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院